Hyperglycemia enhances VSMC proliferation with NF-κB activation by angiotensin II and E2F-1 augmentation by growth factors

Molecular and Cellular Endocrinology

Volumn 192, Issue 1-2, 2002, Pages 75-84

  Fujita, Nobuya ^a   Furukawa, Yusuke ^a   Du, Jian ^a   Itabashi, Naoki ^a   Fujisawa, Genro ^a   Okada, Koji ^a   Saito, Toshikazu ^a   Ishibashi, Shun ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; E2F 1; High glucose; Nuclear factor B; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR E2F; ANGIOTENSIN II; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 1; DNA; DNA BINDING PROTEIN; E2F1 PROTEIN, RAT; GLUCOSE; GROWTH PROMOTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG EFFECT; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HYPERPLASIA; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMAL; CELL DIVISION; CELLS, CULTURED; DNA; FETAL BLOOD; GENE EXPRESSION REGULATION; GLUCOSE; GROWTH SUBSTANCES; HYPERGLYCEMIA; HYPERPLASIA; MALE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN P34CDC2; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ANIMALS; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA;

EID: 0037188819     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00108-9     Document Type: Article

References (37)

1. Hyperglycemia enhances angiotensin II-induced Janus-activated kinase/STAT signaling in vascular smooth muscle cells
2. IκB: A specific inhibitor of the NF-κB transcription factor
3. Cardiac action of angiotensin II: Role of an intracardiac rennin-angiotensin system
4. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells
5. Regulation of E2F: A family of transcription factors involved in proliferation control
6. Vascular dysfunction in diabetes mellitus
7. 2/M transition by ANG II and AVP in vascular smooth muscle cells
8. Hyperinsulinemia enhances transcriptional activity of nuclear factor-κB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells
9. Angiotensin II signaling in vascular smooth muscle. New concepts
10. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors
11. High-glucose-induced nuclear factor κB activation in vascular smooth muscle cells
12. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation
13. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
14. Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells
15. Epidemiological approach to the etiology of type 1 diabetes mellitus and its complications
16. NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
17. Cardiovascular risk factors in type 2 diabetes: The role of hyperglycaemia
18. The E2F transcription factors: Key regulators of cell proliferation
19. Effects of angiotensin converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients
20. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions
21. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats
22. + in vascular smooth muscle cells
23. Acute hyperglycemia regulates transcription and posttranscriptional stability of PKCβII mRNA in vascular smooth muscle cells
24. 2 in vascular smooth muscle cells: Molecular mechanism
25. 1/S boundary-specific enhancer of the rat cdc2 promoter
26. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: Lack of direct growth-promoting effects of high glucose levels
27. NF-κB: A lesson in family values
28. Intensive blood glucose control with sulfonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
29. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells
30. Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells: Role of protein kinase C
31. Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model
32. Induction of vascular cell adhesion molecule-1 expression by IL-4 in human aortic smooth muscle cells is not associated with increased nuclear NF-kappaB levels
33. Intracellular signaling in rat cultured vascular smooth muscle cells: Roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production
34. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
35. Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation
36. Hyperglycemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells
37. 2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats